Application 212264
- Type
- ANDA
- Sponsor
- PRINSTON PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | EMPAGLIFLOZIN AND LINAGLIPTIN | EMPAGLIFLOZIN; LINAGLIPTIN | TABLET;ORAL | 25MG;5MG | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 70089 | ORIG | 2022-02-04 |